Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML |
Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD |
'A' Award Grants |
2012 |
Washington |
Epigenetic Modifiers as Therapeutic Targets in Pediatric T-cell Acute Lymphoblastic Leukemia |
Washington University / Grant Challen, PhD |
'A' Award Grants |
2012 |
Missouri |
BET Bromodomain Inhibition as Epigenetic Therapy in Pediatric Leukemia |
Cold Spring Harbor Laboratory / Christopher Vakoc, MD, PhD |
'A' Award Grants |
2012 |
New York |
Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2012 |
Utah |
Childhood Leukemia in Kenya Identified Through Malaria Slide Review |
Indiana University / Terry Vik |
Epidemiology Grants |
2012 |
Indiana |
Neurofibromatosis Type 1 as a model population for pediatric brain cancer prevention and control research |
Washington University / Kimberly Johnson Ph.D. |
Epidemiology Grants |
2012 |
Missouri |
In-UTR mutations in neuroblastoma: Functional consequences and therapeutic implications |
Children’s Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2012 |
Pennsylvania |
Identification and validation of new therapeutic targets in pediatric leukemia through an aneuploidy-based synthetic lethality screen |
Dana-Farber Cancer Institute / David Pellman, MD |
Innovation Grants |
2012 |
Massachusetts |
Casein Kinase 1 alpha Agonists as Novel Medulloblastoma Inhibitors |
University of Miami Miller School of Medicine / David Robbins, PhD |
Innovation Grants |
2012 |
Florida |
Novel STAT3 drug development for childhood osteosarcoma therapy using drug repositioning |
Research Institute at Nationwide Children's Hospital / Jiayuh Lin, PhD |
Innovation Grants |
2012 |
Ohio |